Philippines approves Pfizer-BioNTech vaccine for emergency use
MANILA (Reuters) - The Philippines' Food and Drug Administration has authorized the emergency use of Pfizer Inc and BioNTech SE's COVID-19 vaccine, its head said on Thursday.
The Pfizer-BioNTech vaccine, which has shown a 95% success rate, is the first vaccine the Philippines has approved.
FDA head Rolando Enrique Domingo told a media briefing China's Sinovac Biotech Ltd on Wednesday submitted to regulators its emergency use authorization application.
(Reporting by Karen Lema; Editing by Ed Davies)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.